Aspergillus fumigatus is clinically the most relevant mold in immunocompromised patients. Azoles are the drugs of choice for treatment of invasive infections ([13][1]). Recently, an increasing number of azole-resistant A. fumigatus isolates in the environment, as well as in patient specimens, have
No takes yet. Share an insight, caveat, or question.
Rath et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: